Advertisement

Topics

STAT Plus: Aerie’s drug manufacturing risk reliever; September biotech events on tap

08:26 EDT 17 Aug 2017 | STAT

An update to my column yesterday about Aerie Pharmaceuticals (AERI) and what I called an under-appreciated manufacturing risk related to its glaucoma drug Rhopressa, now under review at the FDA.…

Original Article: STAT Plus: Aerie’s drug manufacturing risk reliever; September biotech events on tap

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Aerie’s drug manufacturing risk reliever; September biotech events on tap"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...